Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
2013 ◽
Vol 94
(5)
◽
pp. 593-600
◽
M Reilly
◽
R M Miller
◽
M H Thomson
◽
V Patris
◽
P Ryle
◽
...
2013 ◽
Vol 53
(4)
◽
pp. 385-395
◽
Fabrice Balavoine
◽
Michel Azizi
◽
Damien Bergerot
◽
Nadia De Mota
◽
Rémi Patouret
◽
...
2021 ◽
Vol 159
◽
pp. 105724
Qi Shen
◽
Chao Hu
◽
Jia Miao
◽
Junxia Chen
◽
Yueying Peng
◽
...
2018 ◽
Vol 32
(11)
◽
pp. 1053-1067
◽
Lesley Taylor
◽
Barry Gidal
◽
Graham Blakey
◽
Bola Tayo
◽
Gilmour Morrison
2017 ◽
Vol 112
◽
pp. S230
◽
Houssam Halawi
◽
Priya Vijayvargiya
◽
Irene Busciglio
◽
Ibironke Oduyebo
◽
Disha Khemani
◽
...
2016 ◽
Vol 17
(4)
◽
pp. S79
◽
D. Chiche
◽
W. Brown
◽
P. Walker
Ehsanollah Esfandiari
◽
Mary Chen
◽
Glennda Smithson
◽
Derek Blair
◽
Helene Faessel
◽
...
2014 ◽
Vol 9
(1)
◽
pp. e83449
◽
Rigmor Thorstensson
◽
Birger Trollfors
◽
Nabil Al-Tawil
◽
Maja Jahnmatz
◽
Jakob Bergström
◽
...
2019 ◽
Vol 33
(4)
◽
pp. 397-397
Lesley Taylor
◽
Barry Gidal
◽
Graham Blakey
◽
Bola Tayo
◽
Gilmour Morrison
2003 ◽
Vol 124
(4)
◽
pp. A377
◽
Monette M. Cotreau
◽
Lucille Stonis
◽
Ullrich S. Schwertschlag